Complete alcohol abstinence increases the risk of NAFLD but not severity. A population analysis with transient elastography

Abstract Background & Aims As the global prevalence of non-alcoholic fatty liver disease (NAFLD) continues to rise, ubiquity of alcohol use has also prompted discussion regarding the potential interactions between the two. This study aims to examine the effects of modest alcohol consumption on the prevalence and complications of NAFLD in a multi-ethnic population. Methods This study analyses the 2017–2018 cycles of NHANES that examined liver fibrosis and steatosis with vibration controlled transient elastography. A coarsened exact matching was conducted to reduce confounding. Logistic regression was done with a multivariate model to assess the relationship between alcohol consumption (modest drinkers and non-drinkers) and risk of NAFLD and its complications. Results 2,067 individuals were found to have NAFLD and 284 NAFLD patients had a total history of alcohol abstinence. After coarsened exact matching, the prevalence of NAFLD was 49% (CI: 0.41 − 0.58) in non-drinkers and 33% (CI: 0.26 − 0.41) in modest drinkers. Non-drinkers had twice the odds of NAFLD compared to modest drinkers (OR: 1.99, CI: 1.22 − 3.22, p<.01) after adjustment for confounders. There were no significant differences in the odds of significant fibrosis, advance fibrosis, cirrhosis, cardiovascular disease and stroke between non-drinkers and modest drinkers. The odds of malignancy in non-drinkers were almost significantly less than modest drinkers (OR: 0.28, CI:0.08 − 1.02, p=.053). Conclusion Interestingly, modest alcohol consumption is associated with decreased odds of NAFLD. Further investigations are required to examine the relationship between alcohol consumption and NAFLD and subsequently the potential impact on NAFLD management.

[1]  A. Sanyal,et al.  Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals , 2022, Clinical and molecular hepatology.

[2]  A. Sanyal,et al.  A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Non-alcoholic Fatty Liver Disease. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  P. Charatcharoenwitthaya,et al.  The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis , 2021, Frontiers in Medicine.

[4]  A. Sanyal,et al.  A clinical overview of non‐alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications—What the non‐specialist needs to know , 2021, Diabetes, obesity & metabolism.

[5]  A. Lichtenstein,et al.  Alcohol consumption and risk of cardiovascular disease, cancer and mortality: a prospective cohort study , 2021, Nutrition Journal.

[6]  H. Malhi,et al.  Pathogenesis of Nonalcoholic Steatohepatitis: An Overview , 2020, Hepatology communications.

[7]  M. Petroni,et al.  Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? , 2019, Nutrients.

[8]  Yan Liu,et al.  Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis , 2019, Scientific Reports.

[9]  A. Werneck,et al.  Association between physical activity and alcohol consumption: sociodemographic and behavioral patterns in Brazilian adults. , 2018, Journal of public health.

[10]  B. Neuschwander‐Tetri,et al.  Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  Dan J Stein,et al.  Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, Lancet.

[12]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[13]  Jeesun Jung,et al.  Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions , 2017, JAMA psychiatry.

[14]  J. Mi,et al.  Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults. , 2017, Journal of the American College of Cardiology.

[15]  N. Terrault,et al.  Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review , 2017, Hepatology.

[16]  M. Kumar,et al.  Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. , 2017, Journal of hepatology.

[17]  K. Hajifathalian,et al.  Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study , 2017, Hepatology.

[18]  B. Neuschwander‐Tetri Non-alcoholic fatty liver disease , 2017, BMC Medicine.

[19]  Pierre Bedossa,et al.  Pathology of non‐alcoholic fatty liver disease , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[20]  I. Bergheim,et al.  Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice , 2016, European Journal of Nutrition.

[21]  C. Neighbors,et al.  Exercise and Alcohol Consumption: What We Know, What We Need to Know, and Why it is Important , 2015, Front. Psychiatry.

[22]  Kathryn S. Porter,et al.  National Health and Nutrition Examination Survey (NHANES) , 2015 .

[23]  K. Straif,et al.  Alcohol consumption and liver cancer risk: a meta-analysis , 2015, Cancer Causes & Control.

[24]  Mary E Rinella,et al.  Nonalcoholic fatty liver disease: a systematic review. , 2015, JAMA.

[25]  P Boffetta,et al.  Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  F. T. E. Group,et al.  Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women , 2012, Diabetologia.

[27]  Hajime Sato,et al.  Modest alcohol consumption has an inverse association with liver fat content. , 2012, Hepato-gastroenterology.

[28]  N. Chalasani,et al.  Endpoints and clinical trial design for nonalcoholic steatohepatitis , 2011, Hepatology.

[29]  A. Ido,et al.  Alcohol drinking patterns and the risk of fatty liver in Japanese men , 2011, Journal of Gastroenterology.

[30]  W. Ghali,et al.  Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis , 2011, BMJ : British Medical Journal.

[31]  Y. Ohashi,et al.  Alcohol consumption and risk of atrial fibrillation: a meta-analysis. , 2011, Journal of the American College of Cardiology.

[32]  G. King,et al.  Cem: Coarsened Exact Matching in Stata , 2009 .

[33]  M. Holmqvist,et al.  Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease , 2009, Scandinavian journal of gastroenterology.

[34]  M. M. Joosten,et al.  Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial , 2008, Diabetologia.

[35]  V. de Lédinghen,et al.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study , 2005, Gut.

[36]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[37]  K. Reynolds,et al.  Alcohol consumption and risk of stroke: a meta-analysis. , 2003, JAMA.

[38]  P. Taylor,et al.  Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. , 2002, JAMA.

[39]  E. Rimm,et al.  Moderate alcohol consumption and coronary heart disease: a review , 2001, Postgraduate medical journal.

[40]  W. Hauser,et al.  The Protective Effect of Moderate Alcohol Consumption on Ischemic Stroke , 1999 .

[41]  R. Groszmann,et al.  American association for the study of liver diseases , 1992 .

[42]  D. Crabb,et al.  Introducing the 2019 AASLD guidance on Alcohol-related liver disease. , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.